SCHEMBL14129809

SCHEMBL14129809

Bc1cc2c(=O)[nH]c(C)nc2s1

nearest known ligand 0.57

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
KDM4E B2RXH2 3/20 0.57
ALDH1A1 P00352 3/20 0.57
NPC1 O15118 2/20 0.57
MAPT P10636 2/20 0.57
RAB9A P51151 2/20 0.57
SMN1; SMN2 Q16637 2/20 0.57
MAPK1 P28482 1/20 0.45
PARP1 P09874 4/20 0.44
HPGD P15428 2/20 0.42
USP2 O75604 1/20 0.42
GLA P06280 1/20 0.42
GAA P10253 1/20 0.42
TNKS2 Q9H2K2 1/20 0.42
ADORA3 P0DMS8 3/20 0.40
CDC7 O00311 1/20 0.40
DBF4 Q9UBU7 1/20 0.40
TMIGD3 P0DMS9 2/20 0.40
ADORA1 P30542 2/20 0.40
LMNA P02545 1/20 0.40
HSD17B10 Q99714 1/20 0.40

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL5435622 0.82 KDM4E (0.60) KDM4EALDH1A1NPC1MAPTRAB9A
SCHEMBL16652953 0.79 KDM4E (0.57) KDM4EALDH1A1NPC1MAPTRAB9A
SCHEMBL16652890 0.73 RAB9A (1.00) KDM4EALDH1A1NPC1MAPTRAB9A
SCHEMBL19838253 0.72 SMN1; SMN2 (0.50) KDM4EALDH1A1NPC1MAPTRAB9A
SCHEMBL16652889 0.72 KDM4E (0.50) KDM4EALDH1A1NPC1MAPTRAB9A
SCHEMBL654538 0.71 ALDH1A1 (0.75) KDM4EALDH1A1NPC1MAPTRAB9A
SCHEMBL18351098 0.69 KDM4E (0.60) KDM4EALDH1A1NPC1MAPTRAB9A
SCHEMBL16653487 0.69 KDM4E (0.47) KDM4EALDH1A1NPC1MAPTRAB9A
SCHEMBL16659889 0.68 KDM4E (0.46) KDM4EALDH1A1NPC1MAPTRAB9A
SCHEMBL278356 0.68 ALDH1A1 (0.46) KDM4EALDH1A1NPC1MAPTRAB9A

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 7 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
WO-2017031176-A1 MONOCYCLIC, THIENO, PYRIDO, AND PYRROLO PYRIMIDINE COMPOUNDS AND METHODS OF USE AND MANUFACTURE OF THE SAME DUQUESNE UNIVERSITY OF THE HOLY SPIRIT (US) 2017-02-23 WO disclosed
US-20170050978-A1 Monocyclic, Thieno, Pyrido, and Pyrrolo Pyrimidine Compounds and Methods of Use and Manufacture of the Same DUQUESNE UNIVERSITY OF THE HOLY SPIRIT 2017-02-23 US disclosed
US-9402826-B2 Neuronal pain pathway modulators THE TRUSTEES OF COLUMBIA UNIVERSITY IN THE CITY OF NEW YORK (US) 2016-08-02 US disclosed
US-20150126576-A1 NEURONAL PAIN PATHWAY MODULATORS THE TRUSTEES OF COLUMBIA UNIVERSITY IN THE CITY OF NEW YORK (US) 2015-05-07 US disclosed
US-8846742-B2 Neuronal pain pathway modulators THE TRUSTEES OF COLUMBIA UNIVERSITY IN THE CITY OF NEW YORK (US) 2014-09-30 US disclosed
US-8183276-B2 Therapeutic agents MERCK SHARP & DOHME CORP. 2012-05-22 US disclosed
US-20080176920-A1 protein kinase G inhibitors; analogs of balanol THE TRUSTEES OF COLUMBIA UNIVERSITY IN THE CITY OF NEW YORK 2008-07-24 US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (3 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20150126576-A1 NEURONAL PAIN PATHWAY MODULATORS GRIN3A, GRIN3B, OPRK1 KDM4E 3391/4885ALDH1A1 3886/4885NPC1 2389/4885
US-20080176920-A1 protein kinase G inhibitors; analogs of balanol PRKCG, GRK3, PRKG1 KDM4E 2960/4885ALDH1A1 4806/4885NPC1 2206/4885
US-20170050978-A1 Monocyclic, Thieno, Pyrido, and Pyrrolo Pyrimidine Compounds and Methods of Use and Manufacture of the Same CYP4F3, TYMS, DPYD KDM4E 2571/4885ALDH1A1 1573/4885NPC1 810/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.